Evicenter
MarkdownMedical informationP&T meetings
Ifezuntirgene inilparvovec (AMT-130)

Huntington's disease

Manufacturer
uniQure
Launch
Not announced
Last updated
291 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Huntington's disease

Economic burden and healthcare resource utilization

28 evidence topics · 30 sources

Systematic review of cost-of-illness studies: annual costs by stage and cost type (2023 U.S. dollars)
Cost type and study“Early”View highlighted excerpt for this quote“Middle”View highlighted excerpt for this quote“Late”View highlighted excerpt for this quote
Inpatient, Divino“1150”View highlighted excerpt for this quote“5045”View highlighted excerpt for this quote“9216”View highlighted excerpt for this quote
Inpatient, Exuzides“1225”View highlighted excerpt for this quote“4250”View highlighted excerpt for this quote“22,228”View highlighted excerpt for this quote
Inpatient, Patel“791”View highlighted excerpt for this quote“3,070”View highlighted excerpt for this quote“65,465”View highlighted excerpt for this quote
Outpatient, Divino“2956”View highlighted excerpt for this quote“10,508”View highlighted excerpt for this quote“30,104”View highlighted excerpt for this quote
Outpatient, Exuzides“4736”View highlighted excerpt for this quote“10,361”View highlighted excerpt for this quote“13,665”View highlighted excerpt for this quote
Outpatient, Patel“5676”View highlighted excerpt for this quote“11639”View highlighted excerpt for this quote“6226”View highlighted excerpt for this quote
Drug, Divino“2483”View highlighted excerpt for this quote“4518”View highlighted excerpt for this quote“4838”View highlighted excerpt for this quote
Drug, Exuzides“15,663”View highlighted excerpt for this quote“16,790”View highlighted excerpt for this quote“23,944”View highlighted excerpt for this quote
Drug, Patel“6330”View highlighted excerpt for this quote“14149”View highlighted excerpt for this quote“13,108”View highlighted excerpt for this quote
Caregiving, Jones“6073”View highlighted excerpt for this quote“44,662”View highlighted excerpt for this quote“133,200”View highlighted excerpt for this quote
Caregiving, Silva-Pardes“6041”View highlighted excerpt for this quote“16,502”View highlighted excerpt for this quote“21,438”View highlighted excerpt for this quote
HDBOI study: design, participants, and costing methods

“The HDBOI study is a noninterventional, retrospective, cross-sectional, international burden of illness study of people with diagnosed HD in France, Germany, Italy, Spain, the UK, and the USA.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote

“A total of 2094 PwHD were enrolled in the HDBOI study, 40% of whom (n = 846) were classified as ES, 34% as MS (n = 701), and 26% as AS (n = 547; Table 1).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote

“Information regarding HD-related health care resource use used to compute direct medical costs was available for all 2094 PwHD. Information on direct nonmedical costs was available for 359 PwHD and indirect costs for 436 PwHD.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote

“Costs are reported in 2020 euros for all outcomes” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote

“To minimize underestimation of costs due to potentially reduced care interactions during the coronavirus disease 2019 (COVID-19) pandemic, health care resource use (used to compute direct medical costs) was extracted for a set time period before the pandemic (March 2019 through March 2020).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote

“For actively employed PwHD and caregivers, productivity loss was quantified as the number of days missed from work due to HD in the past 3 months multiplied by the country average salary per day.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote

“For those unable to work due to HD, an opportunity cost was assigned based on 1 year of average salary per country.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote

HDBOI study: cost drivers and mean annual cost components by stage (2020 euros)
Cost componentEarly stage, mean (SD) and nMid stage, mean (SD) and nAdvanced stage, mean (SD) and n
Consultations“€727 (€1216) n = 829”View highlighted excerpt for this quote“€767 (€975) n = 693”View highlighted excerpt for this quote“€1051 (€1335) n = 545”View highlighted excerpt for this quote
Hospital inpatient“€35,803 (€102,653) n = 28”View highlighted excerpt for this quote“€30,698 (€39,581) n = 23”View highlighted excerpt for this quote“€12,658 (€42,550) n = 60”View highlighted excerpt for this quote
Treatment“€6333 (€25,525) n = 667”View highlighted excerpt for this quote“€6539 (€28,257) n = 571”View highlighted excerpt for this quote“€7922 (€26,248) n = 454”View highlighted excerpt for this quote
Residential care“€41,879 (€46,946) n = 16”View highlighted excerpt for this quote“€56,673 (€40,806) n = 26”View highlighted excerpt for this quote“€45,977 (€31,915) n = 98”View highlighted excerpt for this quote
Professional caregiver“€1286 (€4355) n = 204”View highlighted excerpt for this quote“€2308 (€9831) n = 164”View highlighted excerpt for this quote“€2582 (€8632) n = 114”View highlighted excerpt for this quote
State support, patient“€841 (€2123) n = 204”View highlighted excerpt for this quote“€1199 (€2497) n = 164”View highlighted excerpt for this quote“€2677 (€3437) n = 114”View highlighted excerpt for this quote
Lost productivity, PwHD“€23,216 (€16,848) n = 75”View highlighted excerpt for this quote“€31,824 (€13,934) n = 109”View highlighted excerpt for this quote“€34,343 (€10,295) n = 98”View highlighted excerpt for this quote
Other countries: Israel, China, Peru, Brazil, and Germany